Marinus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is March - February.

Millions USD. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	May '25 May 3, 2025	Feb '25 Feb 1, 2025	Feb '24 Feb 3, 2024	Jan '23 Jan 28, 2023	Jan '22 Jan 29, 2022	Jan '21 Jan 30, 2021	2017 - 2021
Revenue	11,418	11,296	11,207	10,209	8,631	6,152	Upgrade
Revenue Growth (YoY)	1.06%	0.79%	9.78%	18.28%	40.29%	-16.84%	Upgrade
Cost of Revenue	6,541	6,463	6,393	5,758	4,873	3,817	Upgrade
Gross Profit	4,877	4,833	4,814	4,450	3,758	2,334	Upgrade
Selling, General & Admin	3,299	3,254	3,128	2,801	2,451	1,968	Upgrade
Operating Expenses	3,311	3,268	3,136	2,812	2,460	1,983	Upgrade
Operating Income	1,566	1,565	1,678	1,639	1,297	351.14	Upgrade
Interest Expense	-	-	-	-	-1.66	-5.74	Upgrade
Interest & Investment Income	11.74	15.09	17.62	4.93	-	-	Upgrade
EBT Excluding Unusual Items	1,577	1,580	1,696	1,644	1,296	345.41	Upgrade
Merger & Restructuring Charges	-	-	-	-	-	-72.37	Upgrade
Asset Writedown	-	-	-	-	-	-41.95	Upgrade
Pretax Income	1,577	1,580	1,696	1,644	1,296	231.09	Upgrade
Income Tax Expense	383.86	378.95	404.65	401.14	309.99	55.25	Upgrade
Net Income	1,193	1,201	1,291	1,242	985.84	175.84	Upgrade
Net Income to Common	1,193	1,201	1,291	1,242	985.84	175.84	Upgrade
Net Income Growth	-5.09%	-6.96%	3.91%	26.03%	460.66%	-75.09%	Upgrade
Shares Outstanding (Basic)	47	47	49	51	54	56	Upgrade
Shares Outstanding (Diluted)	47	47	50	52	55	57	Upgrade
Shares Change (YoY)	-4.87%	-4.42%	-4.14%	-5.66%	-3.04%	-2.66%	Upgrade
EPS (Basic)	25.65	25.44	26.18	24.17	18.09	3.12	Upgrade
EPS (Diluted)	25.56	25.34	26.03	24.01	17.98	3.11	Upgrade
EPS Growth	-0.21%	-2.65%	8.41%	33.54%	478.13%	-74.40%	Upgrade
Free Cash Flow	1,037	964.15	1,041	1,170	887.08	658.49	Upgrade
Free Cash Flow Per Share	22.21	20.34	20.99	22.61	16.18	11.64	Upgrade
Gross Margin	42.71%	42.78%	42.95%	43.59%	43.54%	37.95%	Upgrade
Operating Margin	13.71%	13.86%	14.97%	16.05%	15.03%	5.71%	Upgrade
Profit Margin	10.45%	10.63%	11.52%	12.17%	11.42%	2.86%	Upgrade
Free Cash Flow Margin	9.08%	8.54%	9.29%	11.46%	10.28%	10.70%	Upgrade
EBITDA	1,840	1,832	1,921	1,879	1,565	647.99	Upgrade
EBITDA Margin	16.11%	16.22%	17.14%	18.41%	18.13%	10.53%	Upgrade
D&A For EBITDA	274.03	266.74	242.95	240.36	267.53	296.85	Upgrade
EBIT	1,566	1,565	1,678	1,639	1,297	351.14	Upgrade
EBIT Margin	13.71%	13.86%	14.97%	16.05%	15.03%	5.71%	Upgrade
Effective Tax Rate	24.34%	23.98%	23.86%	24.41%	23.92%	23.91%	Upgrade
Advertising Expenses	-	431.46	422.78	374.73	387.79	281.57	Upgrade

Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q